Labile catalytic packaging of DNA/siRNA: control of gold nanoparticles "out" of DNA/siRNA complexes.

A novel approach was developed to efficiently package and deliver nucleic acids with low generation polypropylenimine (PPI) dendrimers by using Au nanoparticles as a "labile catalytic" packaging agent. The gold nanoparticles (Au NPs) helped low generation dendrimers to package nucleic acids into discrete nanoparticles but are not included in the final DNA/siRNA complexes. Therefore it becomes possible to eliminate the potential toxic problems associated with Au NPs by selectively removing the Au NPs from the resulting nucleic acid complexes before their delivery to targeted cells. This is a new concept in using inorganic engineered nanoparticles in nucleic acid packaging and delivery applications. Furthermore, compared to the siRNA nanostructures (mainly randomly aggregated nanofibers) fabricated by low generation dendrimer alone (Generation 3), the siRNA nanoparticles packaged using this novel approach (by Au NPs modified with G3 PPI) can be internalized by cancer cells and the delivered siRNAs can efficiently silence their target mRNA. The efficiency of mRNA silencing by this novel approach is even superior to higher generation dendrimers (Generation 5).

[1]  Yun Chen,et al.  Tumor-targeted delivery of siRNA by self-assembled nanoparticles. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[2]  N. Hud,et al.  Condensation of oligonucleotides assembled into nicked and gapped duplexes: potential structures for oligonucleotide delivery , 2005, Nucleic acids research.

[3]  Y. Won,et al.  Polymer-based siRNA delivery: perspectives on the fundamental and phenomenological distinctions from polymer-based DNA delivery. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[4]  A. Samad,et al.  Dendrimers: a class of polymers in the nanotechnology for the delivery of active pharmaceuticals. , 2009, Current pharmaceutical design.

[5]  Vincent M Rotello,et al.  Toxicity of gold nanoparticles functionalized with cationic and anionic side chains. , 2004, Bioconjugate chemistry.

[6]  F. Szoka,et al.  In vitro gene delivery by degraded polyamidoamine dendrimers. , 1996, Bioconjugate chemistry.

[7]  E. W. Meijer,et al.  Protonation Mechanism of Poly(propylene imine) Dendrimers and Some Associated Oligo Amines , 1997 .

[8]  Warren C W Chan,et al.  Elucidating the mechanism of cellular uptake and removal of protein-coated gold nanoparticles of different sizes and shapes. , 2007, Nano letters.

[9]  C. Sung,et al.  ENZYMATIC SYNTHESIS OF MOLECULAR COMPLEXES OF POLYANILINE WITH DNA AND SYNTHETIC OLIGONUCLEOTIDES: THERMAL AND MORPHOLOGICAL CHARACTERIZATION , 2001 .

[10]  E. Wang,et al.  One-step preparation and characterization of poly(propyleneimine) dendrimer-protected silver nanoclusters , 2004 .

[11]  Nastassja A. Lewinski,et al.  Cytotoxicity of nanoparticles. , 2008, Small.

[12]  Alexander M. Klibanov,et al.  Conjugation to gold nanoparticles enhances polyethylenimine's transfer of plasmid DNA into mammalian cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[13]  J. Dennig,et al.  Gene transfer into eukaryotic cells using activated polyamidoamine dendrimers. , 2002, Journal of biotechnology.

[14]  P. Heegaard,et al.  Dendrimers in Drug Research , 2004 .

[15]  L. Samuelson,et al.  The Role of Template in the Enzymatic Synthesis of Conducting Polyaniline , 1999 .

[16]  M. Pagel,et al.  Tracking the relative in vivo pharmacokinetics of nanoparticles with PARACEST MRI. , 2009, Molecular pharmaceutics.

[17]  Seungpyo Hong,et al.  Interaction of poly(amidoamine) dendrimers with supported lipid bilayers and cells: hole formation and the relation to transport. , 2004, Bioconjugate chemistry.

[18]  L. A. Baker,et al.  Preparation and characterization of dendrimer-gold colloid nanocomposites. , 1999, Analytical chemistry.

[19]  Choon Nam Ong,et al.  Gold Nanoparticles Induce Oxidative Damage in Lung Fibroblasts In Vitro , 2008 .

[20]  A. Schätzlein,et al.  Dendrimers in gene delivery. , 2005, Advanced drug delivery reviews.

[21]  J. Baker,et al.  Efficient transfer of genetic material into mammalian cells using Starburst polyamidoamine dendrimers. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[22]  Shuming Nie,et al.  Proton-sponge coated quantum dots for siRNA delivery and intracellular imaging. , 2008, Journal of the American Chemical Society.

[23]  T. Thomas,et al.  Oligodeoxynucleotide nanostructure formation in the presence of polypropyleneimine dendrimers and their uptake in breast cancer cells , 2006 .

[24]  Bradley D. Smith,et al.  High-generation polycationic dendrimers are unusually effective at disrupting anionic vesicles: membrane bending model. , 2000, Bioconjugate chemistry.

[25]  S. Uprichard.  The therapeutic potential of RNA interference , 2005, FEBS Letters.

[26]  E. Siochi,et al.  Adhesion study of polyimide to single-wall carbon nanotube bundles by energy-filtered transmission electron microscopy , 2003 .

[27]  L. Samuelson,et al.  Manipulating DNA Conformation Using Intertwined Conducting Polymer Chains , 2001 .

[28]  Guojin Zhang,et al.  Polyaniline nanowires on Si surfaces fabricated with DNA templates. , 2004, Journal of the American Chemical Society.

[29]  Michael B. Hall,et al.  Dendritic macromolecules: synthesis of starburst dendrimers , 1986 .

[30]  Shan Jiang,et al.  Quantum-dot based nanoparticles for targeted silencing of HER2/neu gene via RNA interference. , 2007, Biomaterials.

[31]  C. R. Middaugh,et al.  Structure/function relationships of polyamidoamine/DNA dendrimers as gene delivery vehicles. , 2005, Journal of pharmaceutical sciences.

[32]  R. Albrecht,et al.  Toxicity assessments of multisized gold and silver nanoparticles in zebrafish embryos. , 2009, Small.

[33]  N. Bessis,et al.  Immune responses to gene therapy vectors: influence on vector function and effector mechanisms , 2004, Gene therapy.

[34]  Vincent M Rotello,et al.  Gold nanoparticle-mediated transfection of mammalian cells. , 2002, Bioconjugate chemistry.

[35]  E. W. Meijer,et al.  Dendrimers: relationship between structure and biocompatibility in vitro, and preliminary studies on the biodistribution of 125I-labelled polyamidoamine dendrimers in vivo. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[36]  Sabine Neuss,et al.  Size-dependent cytotoxicity of gold nanoparticles. , 2007, Small.

[37]  Huixin He,et al.  DNA and carbon nanotubes as medicine. , 2010, Advanced drug delivery reviews.

[38]  Z. Sideratou,et al.  Quaternized Poly(propylene imine) Dendrimers as Novel pH-Sensitive Controlled-Release Systems , 2000 .

[39]  Leaf Huang,et al.  Targeted delivery of antisense oligodeoxynucleotide and small interference RNA into lung cancer cells. , 2006, Molecular pharmaceutics.

[40]  Anthony Atala,et al.  Gold Nanoparticles Inhibit VEGF165-Induced Proliferation of HUVEC Cells , 2004 .

[41]  E. Wang,et al.  One-Step Synthesis and Size Control of Dendrimer-Protected Gold Nanoparticles: A Heat-Treatment-Based Strategy , 2003 .

[42]  E. Stachowiak,et al.  Organically modified silica nanoparticles: a nonviral vector for in vivo gene delivery and expression in the brain. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[43]  F. Vögtle,et al.  Dendrimers and Dendrons: Concepts, Syntheses, Applications , 2001 .

[44]  M. Borkovec,et al.  Microscopic protonation equilibria of Poly(amidoamine) dendrimers from macroscopic titrations , 2003 .

[45]  E. W. Meijer,et al.  Poly(propylene imine) dendrimers , 1999 .

[46]  T. Thomas,et al.  DNA nanoparticles and development of DNA delivery vehicles for gene therapy. , 2002, Biochemistry.

[47]  Richard M. Crooks,et al.  Preparation and characterization of dendrimer monolayers and dendrimer - Alkanethiol mixed monolayers adsorbed to gold , 1998 .

[48]  H. Paik,et al.  Ionization of Poly(ethylenimine) and Poly(allylamine) at Various pH′s , 1994 .

[49]  J. Dennig,et al.  Gene transfer in eukaryotic cells using activated dendrimers. , 2003, Topics in current chemistry.

[50]  M. Prato,et al.  Functionalized carbon nanotubes for plasmid DNA gene delivery. , 2004, Angewandte Chemie.

[51]  J. Lieberman,et al.  THE SILENT REVOLUTION : RNA Interference as Basic Biology , Research Tool , and Therapeutic , 2010 .

[52]  T. Thomas,et al.  Nanotechnology in Nonviral Gene Delivery , 2005 .

[53]  H. Dai,et al.  Carbon nanotubes in biology and medicine: In vitro and in vivo detection, imaging and drug delivery , 2009, Nano research.

[54]  M. Borkovec,et al.  Acid-base properties of poly(propylene imine)dendrimers , 1998 .

[55]  Abraham Ulman,et al.  Adverse effects of citrate/gold nanoparticles on human dermal fibroblasts. , 2006, Small.

[56]  Victor S-Y Lin,et al.  A polyamidoamine dendrimer-capped mesoporous silica nanosphere-based gene transfection reagent. , 2004, Journal of the American Chemical Society.